These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 420348)

  • 1. Withdrawal from endogenous opiates.
    Julius DA
    Am J Psychiatry; 1979 Mar; 136(3):358-9. PubMed ID: 420348
    [No Abstract]   [Full Text] [Related]  

  • 2. Possible withdrawal from endogeneous opiates in schizophrenics.
    Gitlin M; Rosenblatt M
    Am J Psychiatry; 1978 Mar; 135(3):377-8. PubMed ID: 626239
    [No Abstract]   [Full Text] [Related]  

  • 3. Naltrexone, opiate addiction, and endorphins.
    Gold MS; Dackis CA; Pottash AL; Sternbach HH; Annitto WJ; Martin D; Dackis MP
    Med Res Rev; 1982; 2(3):211-46. PubMed ID: 6289026
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of naloxone and naltrexone in different types of psychoses.
    Volavka J
    Mod Probl Pharmacopsychiatry; 1981; 17():202-12. PubMed ID: 6276726
    [No Abstract]   [Full Text] [Related]  

  • 5. Naltrexone effects on morphine and food self-administration in morphine-dependent rhesus monkeys.
    Mello NK; Mendelson JH; Bree MP
    J Pharmacol Exp Ther; 1981 Aug; 218(2):550-7. PubMed ID: 7195937
    [No Abstract]   [Full Text] [Related]  

  • 6. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.
    Resnick RB; Kestenbaum RS; Washton A; Poole D
    Clin Pharmacol Ther; 1977 Apr; 21(4):409-13. PubMed ID: 849672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Gold MS; Dackis CA; Washton AM
    Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone in a behavioral treatment program.
    O'Brien C; Greenstein R
    NIDA Res Monogr; 1976 Sep; (9):136-40. PubMed ID: 63915
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Treatment of accidental naltrexone-induced withdrawal.
    Volavka J; Resnick RB
    Am J Psychiatry; 1976 Feb; 133(2):233. PubMed ID: 56139
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity of naloxone and naltrexone on the development of the morphine withdrawal syndrome].
    Piccinelli D; de Feo G; Mazzanti G
    Boll Soc Ital Biol Sper; 1986 Oct; 62(10):1221-8. PubMed ID: 3828120
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of prolactin release by endogenous opiates.
    Grandison L; Guidotti A
    Nature; 1977 Nov; 270(5635):357-9. PubMed ID: 201861
    [No Abstract]   [Full Text] [Related]  

  • 12. The future of naltrexone.
    Renault PF
    NIDA Res Monogr; 1978; (19):340-5. PubMed ID: 106298
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of naltrexone in the treatment of schizophrenia.
    Gitlin MJ; Gerner RH; Rosenblatt M
    Psychopharmacology (Berl); 1981; 74(1):51-3. PubMed ID: 6791204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of morphine withdrawal in the dependent rat: suppression by opiate and nonopiate drugs.
    Holtzman SG
    J Pharmacol Exp Ther; 1985 Apr; 233(1):80-6. PubMed ID: 4039002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of narcotic antagonists.
    O'Brien CP; Greenstein R; Ternes J; Woody GE
    Ann N Y Acad Sci; 1978; 311():232-40. PubMed ID: 369432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of electro-acupuncture on naloxone-induced morphine withdrawal in mice: elevation of brain opiate-like activity.
    Ho WK; Wen HL; Lam S; Ma L
    Eur J Pharmacol; 1978 May; 49(2):197-9. PubMed ID: 566205
    [No Abstract]   [Full Text] [Related]  

  • 17. Reinstatement of precipitated narcotic withdrawal hypothermia in the rat.
    Ary M; Lomax P
    Life Sci; 1976 Jun; 18(11):1199-202. PubMed ID: 945438
    [No Abstract]   [Full Text] [Related]  

  • 18. Clonidine and naltrexone. A safe, effective, and rapid treatment of abrupt withdrawal from methadone therapy.
    Charney DS; Riordan CE; Kleber HD; Murburg M; Braverman P; Sternberg DE; Heninger GR; Redmond DE
    Arch Gen Psychiatry; 1982 Nov; 39(11):1327-32. PubMed ID: 7138234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
    Recant L; Voyles NR; Luciano M; Pert CB
    Peptides; 1980; 1(4):309-13. PubMed ID: 6272240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged excretion of morphine in rats during protracted abstinence: lack of effect of naltrexone.
    Jones AW; Neri A; Anggård E
    J Pharmacol Exp Ther; 1983 Feb; 224(2):419-23. PubMed ID: 6681633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.